Speakers from Greenberg Traurig, Verdiva Bio, Halozyme, and Metsera discuss the implications of the USPTO’s 2024 §112 guidelines on life sciences patents. If you don't have a login or your access has ...

Global law firm and Wall Street institution to join forces, forming one of the world’s five largest law firms by revenue and significantly expanding global and US market reach. If you don't have a ...

Dirk Buehler, Maiwald, discusses how the “try and see” standard is applied before the EPO and its relevance in pharma and biotech cases. If you don't have a login or your access has expired, you will ...

Amanda Simons, J A Kemp, explains how clinical research affects patentability in Europe and how clinical data can be used to strengthen protection. If you don't have a login or your access has expired ...

WATCH: Behind the scenes of big ticket litigation — lessons from the courts ...

The firm’s new hire is known for advising Boston’s biotech, pharmaceutical and chemical companies on patent strategies and ...

The proponents of a petition denied by the Supreme Court said it addressed a conflict that was significant “not just for the ...

Companies that integrate data rights into their IP strategy with a holistic approach will lead in innovation while minimising ...

The High Court’s ruling clarifies aspects of the SPC waiver but leaves unresolved questions relating to export-country rights and confidentiality, say Claire Phipps-Jones and Luke Norton of Bristows.

The proposed 1,400-strong firm will combine Taylor Wessing's top UK and European practice with Winston & Strawn's US-focused ...

8 April 2025 The court hands Edwards Lifesciences a win in its long-running battle with Meril | Panel issues a second Europe-wide injunction over prosthetic heart valve technology | Judges reject ...

The country aims to become the world’s third-largest life sciences economy by 2035, but stalled investments, regulatory ...